Drugs / Longidaza
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT06458543 | Jun 2024 → Jun 2025 | bacterial vaginosis | I.M. Sechenov First Moscow State Medical University | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Longidaza | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06458543 ↗ |